Assessing the Impact of Plasma Cell-Free DNA Methylation Monitoring on Predicting Pathological Outcomes in Resectable Stage IIB-IIIB Non-Small Cell Lung Cancer: Insights from a Prospective Phase II Study - Quiz - MDSpire

Assessing the Impact of Plasma Cell-Free DNA Methylation Monitoring on Predicting Pathological Outcomes in Resectable Stage IIB-IIIB Non-Small Cell Lung Cancer: Insights from a Prospective Phase II Study

  • By

  • Bing Liu

  • Ye Tao

  • Minglei Zhuo

  • Li-Di Xu

  • Xueyan Cheng

  • Wei Tao

  • Zhangdong Xie

  • Chao Lv

  • Yuzhao Wang

  • Shaolei Li

  • Shanyuan Zhang

  • Miao Huang

  • Yaqi Wang

  • Xiang Li

  • Yuge Zhu

  • Xinrui Cui

  • Xuantong Zhou

  • Bateer Han

  • Enli Zhang

  • Yu S. Huang

  • Weizhi Chen

  • Jia Wang

  • Shi Yan

  • Nan Wu

  • November 5, 2025

  • 0 min

Share

Original Source(s)

Assessing the Impact of Plasma Cell-Free DNA Methylation Monitoring on Predicting Pathological Outcomes in Resectable Stage IIB-IIIB Non-Small Cell Lung Cancer: Insights from a Prospective Phase II Study

  • by Bing Liu, Ye Tao, Minglei Zhuo, Li-Di Xu, Xueyan Cheng, Wei Tao, Zhangdong Xie, Chao Lv, Yuzhao Wang, Shaolei Li, Shanyuan Zhang, Miao Huang, Yaqi Wang, Xiang Li, Yuge Zhu, Xinrui Cui, Xuantong Zhou, Bateer Han, Enli Zhang, Yu S. Huang, Weizhi Chen, Jia Wang, Shi Yan, Nan Wu

  • November 5, 2025

Related Content

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study

Gastric-type endocervical adenocarcinoma with Peutz-Jeghers syndrome: a case report and literature review